Y-Intercept (HK)’s Solid Biosciences SLDB Stock Holding History

Y-Intercept (HK)’s Portfolio SLDB Stock Details SLDB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Buy	+109,886	New	+$833K	0.02%	1012
2026 Q1	–	Sell	-36,147	Closed	-$204K	–	2012
2025 Q4	$204K	Buy	+36,147	New	+$196K	﹤0.01%	1437
2024 Q3	–	Sell	-40,430	Closed	-$229K	–	1767
2024 Q2	$229K	Buy	+40,430	New	+$362K	0.01%	1128

Other funds holding SLDB

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Y-Intercept (HK)'s SLDB Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Solid Biosciences (SLDB) in Q2 2026: 109,886 shares worth $1.1M. The stake represents 0.02% of the portfolio and ranks #1012 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in SLDB as recently as Q4 2025.

Y-Intercept (HK) first reported a position in SLDB in Q2 2024 and has held it in 3 quarters since. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

Y-Intercept (HK) held 109,886 shares of Solid Biosciences worth $1.1M as of Q2 2026.
Solid Biosciences was a new Y-Intercept (HK) position in Q2 2026.
Solid Biosciences made up 0.02% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1012 holding.
Y-Intercept (HK) first reported a position in Solid Biosciences in Q2 2024 and has held it in 3 quarters since.
157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.